Longtime LCGC contributor Dr. Frantisek Svec will receive the prestigious Dal Nogare Award at Pittcon 2009 in Chicago during a technical session on Monday morning.
Longtime LCGC contributor Dr. Frantisek Svec will receive the prestigious Dal Nogare Award at Pittcon 2009 in Chicago during a technical session on Monday morning.
Svec will be presented with the award by LCGC columnist Dr. Ron Majors and then kick off the session with a presentation on “Porous Polymer Monoliths Today, Tomorrow, and Beyond.” Mary Ellen McNally of DuPont Crop Protection will preside over the session.
Svec has twice contributed to the LCGC supplement on “Recent Developments in LC Column Technology” that is organized by Majors. In 2006, he teamed with Laurent Geiser on an article titled “Monolithic Stationary Phases for HPLC and Sample Preparation” and, in 2008, combined with Jana Krenkova on the effort called “Rigid Porous Polymer Monoliths as Stationary Phases and Supports.”
Svec is the Facility Director of the Molecular Foundry at the E.O. Lawrence Berkeley National Laboratory where he has been since 2005, as well as a Professor at the University of California, Berkeley from 1997. He received his Ph.D. degree in Polymer Chemistry at the Institute of Chemical Technology, Prague in the Czech Republic in 1969, and then spent seven years on the faculty there as an Assistant Professor. After a position as a visiting scientist at the University of Karlsruhe in Germany, Professor Svec returned to Czech Republic and was a Scientific Secretary and Technology Transfer Manager at the Institute of Macromolecular Chemistry, Czech Academy of Sciences in Prague. He then joined the faculty at Cornell University in New York from 1992 to 1996 before assuming his current position at Berkeley. His main research interests are in analytical and polymer chemistry.
Also presenting during the morning session will be Luis Antonio Colon of the University at Buffalo – SUNY, R. Kenneth Marcus of Clemson University, Milton L. Lee of Brigham Young University, and Christopher A. Pohl of Dionex Corporation.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.